22 Jul Angiocrine Bioscience

Posted at 18:01h in by Jancee Curl

Paul Finnegan, M.D., CEO

Oct. 12 | 1:30pm | BlueRock Therapeutics Ballroom

San Diego, CA
(Private)

In-person Presentation
Angiocrine Bioscience aims to transform medicine by harnessing the natural powers of endothelial cells to enable the repair of tissues and organs for patients with life-threatening and debilitating conditions through its proprietary, genetically engineered, E-CEL technology platform.
www.angiocrinebioscience.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 11-13, 2022
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions